Cartesian Therapeutics Competitors and Similar CompaniesClear all
Cartesian Therapeutics's competitors and similar companies include UCB and Ipsen.
 Cartesian Therapeutics Cartesian Therapeutics (formerly Selecta Biosciences) is a clinical-stage biopharmaceutical company advancing a differentiated product pipeline to modulate the immune system. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 2007 | Founding Date 1928 | Founding Date 1929 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Watertown, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more |
Employees | Employees 15 | Employees 9,052 | Employees 5,358 |
Valuation ($) | Valuation ($) 536.3 m | Valuation ($) 34.3 b | Valuation ($) 10.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) $2.8m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods €659.1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €7.2b (FY, 2025) | Gross profit €3.3b (FY, 2025) |
Net income | Net income ($130.3m) (FY, 2025) | Net income €1.6b (FY, 2025) | Net income €445.1m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company